Mylan
News/ News/ Sales and Marketing
FTC clears Mylan merger with Pfizer’s Upjohn – with conditions
Phil Taylor
competition, generic, M&A, Mylan, Pfizer, regulatory, Viatris
0 Comment
Coronavirus pandemic delay Mylan and Pfizer’s generics merger
Richard Staines
coronavirus, COVID-19, generics, M&A, Mylan, Pfizer
0 Comment
COVID-19 could disrupt supplies of cheap generics, analysts warn
Richard Staines
antivirals, coronavirus, COVID-19, generics, infectious diseases, manufacturing, Mylan, Teva, vaccine
0 Comment
News/ News/ Sales and Marketing
Biogen claims victory in patent dispute with Mylan over MS drug Tecfidera
Phil Taylor
Biogen, generic, Mylan, patent, Tecfidera
0 Comment
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Phil Taylor
Advair, asthma, Chronic Obstructive Pulmonary Disease, generic, GlaxoSmithKline, Hikma, Mylan, respiratory, Sandoz
0 Comment
Mylan’s Lantus biosimilar held up by manufacturing issue
Phil Taylor
Biocon, biosimilar, Diabetes, insulin, Lantus, Mylan, Sanofi
0 Comment
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Phil Taylor
Alimta, Eli Lilly, generic, lung cancer, Mylan
0 Comment